AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 169 filers reported holding AXSOME THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $1,369,000 | -5.9% | 20,300 | -21.0% | 0.01% | -10.0% |
Q1 2021 | $1,455,000 | -30.5% | 25,700 | 0.0% | 0.01% | -41.2% |
Q4 2020 | $2,094,000 | +14.4% | 25,700 | 0.0% | 0.02% | -15.0% |
Q3 2020 | $1,831,000 | -13.4% | 25,700 | 0.0% | 0.02% | -13.0% |
Q2 2020 | $2,115,000 | -10.3% | 25,700 | -35.9% | 0.02% | -28.1% |
Q1 2020 | $2,359,000 | -62.0% | 40,100 | -33.3% | 0.03% | -41.8% |
Q4 2019 | $6,212,000 | +193.2% | 60,100 | -42.6% | 0.06% | +175.0% |
Q3 2019 | $2,119,000 | -28.3% | 104,700 | -8.7% | 0.02% | -25.9% |
Q2 2019 | $2,954,000 | +13.8% | 114,700 | -37.1% | 0.03% | +22.7% |
Q1 2019 | $2,596,000 | +177.1% | 182,400 | -45.1% | 0.02% | +175.0% |
Q4 2018 | $937,000 | -18.3% | 332,400 | 0.0% | 0.01% | 0.0% |
Q3 2018 | $1,147,000 | -59.7% | 332,400 | -62.6% | 0.01% | -60.0% |
Q2 2018 | $2,843,000 | +21.4% | 888,400 | -7.1% | 0.02% | +25.0% |
Q1 2018 | $2,342,000 | -52.5% | 956,000 | +8.5% | 0.02% | -51.5% |
Q4 2017 | $4,934,000 | +0.9% | 881,000 | 0.0% | 0.03% | +3.1% |
Q3 2017 | $4,890,000 | +0.9% | 881,000 | 0.0% | 0.03% | 0.0% |
Q2 2017 | $4,846,000 | +41.0% | 881,000 | 0.0% | 0.03% | +45.5% |
Q1 2017 | $3,436,000 | – | 881,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |